Cyclooxygenase-3

COX-3 is transcribed from the PTGS1 (COX1) gene, but the resulting mRNA is spliced differently. In dogs the resulting protein resembles the other two COX enzymes, but in mice and humans it does not, owing to a frame-shift mechanism. This mechanism is due to the fact that the spliced intron has 93 bases in dogs, resulting in the loss of 93:3 = 31 amino acids in the COX-3 sequence, which apparently does not impair its functionality. In humans, the intron is 94 bases long, leading to a protein with a completely different amino acid sequence from those of COX-1 or COX-2. The expressed protein does not show COX activity, and it is unlikely to play a role in prostaglandin-mediated physiological responses.{{Citation needed|date=March 2011}}

The original COX-1/COX-2 model did not fully explain the immune responses of fever and inflammation. Even though COX-2 inhibitors are as active as traditional NSAIDs in inflammatory models, there were still some unexplained issues. For example, the widespread use of the newer generation of COX-2-selective compounds demonstrated that COX-2 also has other physiological roles, e.g. in the maintenance of fluid balance by the kidneys. In addition, the COX-1/COX-2 model did not explain the properties of paracetamol (acetaminophen): although its antipyretic (fever reducing) and analgesic (pain relieving) effects might be explained by inhibition of COX-2, it is not anti-inflammatory. Daniel L. Simmons' group suggested this was because of the presence of a variant of COX-1, which they named COX-3, that would be especially sensitive to paracetamol and related compounds. If this enzyme were particularly expressed in the brain, it could explain both the characteristics of paracetamol, which has been reputed for some time of being a centrally-acting antipyretic.

COX-3 was actually discovered in 2002, and been found to be selectively inhibited by paracetamol, phenacetin, antipyrine, aminopyrine, dipyrone, and strongly inhibited by diclofenac, indomethacin, ibuprofen and aspirin in rodent studies. Acetaminophen is thought of as a mild analgesic and antipyretic suitable, at best, for mild to moderate pain. Its site of action has recently been identified as a COX-3 isoenzyme, a variant of the COX-1 enzyme.{{Cite journal |last=Schwab |first=Jan M. |last2=Schluesener |first2=Hermann J. |last3=Meyermann |first3=Richard |last4=Serhan |first4=Charles N. |date=2003 |title=COX-3 the enzyme and the concept: steps towards highly specialized pathways and precision therapeutics? |journal=Prostaglandins, Leukotrienes, and Essential Fatty Acids |volume=69 |issue=5 |pages=339–343 |doi=10.1016/j.plefa.2003.07.003 |issn=0952-3278 |pmid=14580368}}{{Cite journal |last=Ayoub |first=Samir S. |last2=Botting |first2=Regina M. |last3=Goorha |first3=Sarita |last4=Colville-Nash |first4=Paul R. |last5=Willoughby |first5=Derek A. |last6=Ballou |first6=Leslie R. |date=2004-07-27 |title=Acetaminophen-induced hypothermia in mice is mediated by a prostaglandin endoperoxide synthase 1 gene-derived protein |journal=Proceedings of the National Academy of Sciences of the United States of America |volume=101 |issue=30 |pages=11165–11169 |doi=10.1073/pnas.0404185101 |issn=0027-8424 |pmc=503757 |pmid=15263079}} This discovery raises the possibility of developing more potent and selective drugs targeting the site.

A number of arguments counted against the COX-3 hypothesis: COX-2-selective inhibitors react weakly with the COX-3 enzymatic site, because the site is identical to that in COX-1, but they are as good at reducing fever as older NSAIDs. The fever response has also been clearly associated with a rapid induction of COX-2 expression and an associated increase in prostaglandin E2 production, with no role for COX-1 or a COX-1 gene product (e.g., COX-3). Finally, the sites of COX-3 expression do not appear to fit in well with those sites associated with fever, and the protein should be present within the hypothalamus rather than the cerebral cortex. All these considerations appeared to argue against COX-3 being the site of the antipyretic actions of NSAIDs and COX-2-selective agents. However, the results could be read as showing that paracetamol acts at a different site than the other NSAIDs and that more than one COX isoform contribute to the fever response.{{Cite journal |last=Berenbaum |first=Francis |date=2004 |title=COX-3: Fact or fancy? |journal=Joint Bone Spine |language=en |volume=71 |issue=6 |pages=451–453 |doi=10.1016/j.jbspin.2004.02.003}}

Finally, the discovery of the frame-shift mechanism has made it highly unlikely that COX-3 plays a role in inflammation and fever in humans.{{Citation needed|date=April 2024}}

{{Reflist}}

{{refbegin | colwidth = 30em }}

• {{cite journal |vauthors=Aronoff DM, Neilson EG | title = Antipyretics: mechanisms of action and clinical use in fever suppression | journal = Am. J. Med. | volume = 111 | issue = 4 | pages = 304–15 |date=September 2001 | pmid = 11566461 | doi = 10.1016/S0002-9343(01)00834-8}}.
• {{cite journal | author = Botting R | title = Paracetamol-inhibitable COX-2 | journal = J. Physiol. Pharmacol. | volume = 51 | issue = 4 Pt 1 | pages = 609–18 |date=December 2000 | pmid = 11192935 }}
• {{cite journal |vauthors=Boutaud O, Aronoff DM, Richardson JH, Marnett LJ, Oates JA | title = Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H(2) synthases | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 99 | issue = 10 | pages = 7130–5 |date=May 2002 | pmid = 12011469 | pmc = 124540 | doi = 10.1073/pnas.102588199 | bibcode = 2002PNAS...99.7130B | doi-access = free }}
• {{cite journal |vauthors=Camu F, Beecher T, Recker DP, Verburg KM | title = Valdecoxib, a COX-2-specific inhibitor, is an efficacious, opioid-sparing analgesic in patients undergoing hip arthroplasty | journal = Am J Ther | volume = 9 | issue = 1 | pages = 43–51 | year = 2002 | pmid = 11782819 | doi = 10.1097/00045391-200201000-00009| s2cid = 10726593 }}
• {{cite journal |vauthors=Cao C, Matsumura K, Yamagata K, Watanabe Y | title = Endothelial cells of the rat brain vasculature express cyclooxygenase-2 mRNA in response to systemic interleukin-1 beta: a possible site of prostaglandin synthesis responsible for fever | journal = Brain Res. | volume = 733 | issue = 2 | pages = 263–72 |date=September 1996 | pmid = 8891309 | doi = 10.1016/0006-8993(96)00575-6| s2cid = 7960474 }}
• {{cite journal |vauthors=Chandrasekharan NV, Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS, Simmons DL | title = COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 99 | issue = 21 | pages = 13926–31 |date=October 2002 | pmid = 12242329 | pmc = 129799 | doi = 10.1073/pnas.162468699 | doi-access = free }}–13931.
• {{cite journal |vauthors=Chang DJ, Desjardins PJ, Chen E, Polis AB, McAvoy M, Mockoviak SH, Geba GP | title = Comparison of the analgesic efficacy of rofecoxib and enteric-coated diclofenac sodium in the treatment of postoperative dental pain: a randomized, placebo-controlled clinical trial | journal = Clin Ther | volume = 24 | issue = 4 | pages = 490–503 |date=April 2002 | pmid = 12017395 | doi = 10.1016/S0149-2918(02)85126-8}}
• {{cite journal |vauthors=Dougados M, Béhier JM, Jolchine I, Calin A, van der Heijde D, Olivieri I, Zeidler H, Herman H | title = Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: a six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug | journal = Arthritis Rheum. | volume = 44 | issue = 1 | pages = 180–5 |date=January 2001 | pmid = 11212158 | doi = 10.1002/1529-0131(200101)44:1<180::AID-ANR24>3.0.CO;2-K | doi-access = }}
• {{cite journal | author = FitzGerald GA | title = Cardiovascular pharmacology of nonselective nonsteroidal anti-inflammatory drugs and coxibs: clinical considerations | journal = Am. J. Cardiol. | volume = 89 | issue = 6A | pages = 26D–32D |date=March 2002 | pmid = 11909558 | doi =10.1016/S0002-9149(02)02234-8 }}
• {{cite journal |vauthors=Fletcher BS, Kujubu DA, Perrin DM, Herschman HR | title = Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase | journal = J. Biol. Chem. | volume = 267 | issue = 7 | pages = 4338–44 |date=March 1992 | doi = 10.1016/S0021-9258(18)42840-2 | pmid = 1339449 | doi-access = free }}
• {{cite journal |vauthors=Flower RJ, Vane JR | title = Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol) | journal = Nature | volume = 240 | issue = 5381 | pages = 410–1 |date=December 1972 | pmid = 4564318 | doi = 10.1038/240410a0| bibcode = 1972Natur.240..410F | s2cid = 4174100 }}
• {{cite journal |vauthors=Gordon SM, Brahim JS, Rowan J, Kent A, Dionne RA | title = Peripheral prostanoid levels and nonsteroidal anti-inflammatory drug analgesia: replicate clinical trials in a tissue injury model | journal = Clin. Pharmacol. Ther. | volume = 72 | issue = 2 | pages = 175–83 |date=August 2002 | pmid = 12189364 | doi = 10.1067/mcp.2002.126501 | s2cid = 32072662 }}
• {{cite journal |vauthors=Grèen K, Drvota V, Vesterqvist O | title = Pronounced reduction of in vivo prostacyclin synthesis in humans by acetaminophen (paracetamol) | journal = Prostaglandins | volume = 37 | issue = 3 | pages = 311–5 |date=March 1989 | pmid = 2664901 | doi = 10.1016/0090-6980(89)90001-4}}
• {{cite journal |vauthors=Henry D, Lim LL, Garcia Rodriguez LA, Perez Gutthann S, Carson JL, Griffin M, Savage R, Logan R, Moride Y, Hawkey C, Hill S, Fries JT | title = Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis | journal = BMJ | volume = 312 | issue = 7046 | pages = 1563–6 |date=June 1996 | pmid = 8664664 | pmc = 2351326 | doi = 10.1136/bmj.312.7046.1563}}
• {{cite journal |vauthors=Khan KN, Paulson SK, Verburg KM, Lefkowith JB, Maziasz TJ | title = Pharmacology of cyclooxygenase-2 inhibition in the kidney | journal = Kidney Int. | volume = 61 | issue = 4 | pages = 1210–9 |date=April 2002 | pmid = 11918727 | doi = 10.1046/j.1523-1755.2002.00263.x | doi-access = free }}
• {{cite journal |vauthors=Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR | title = TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue | journal = J. Biol. Chem. | volume = 266 | issue = 20 | pages = 12866–72 |date=July 1991 | doi = 10.1016/S0021-9258(18)98774-0 | pmid = 1712772 | doi-access = free }}
• {{cite journal |vauthors=Kurumbail RG, Stevens AM, Gierse JK, McDonald JJ, Stegeman RA, Pak JY, Gildehaus D, Miyashiro JM, Penning TD, Seibert K, Isakson PC, Stallings WC | title = Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents | journal = Nature | volume = 384 | issue = 6610 | pages = 644–8 | year = 1996 | pmid = 8967954 | doi = 10.1038/384644a0 | bibcode = 1996Natur.384..644K | s2cid = 4326310 }}
• {{cite journal |vauthors=Li S, Wang Y, Matsumura K, Ballou LR, Morham SG, Blatteis CM | title = The febrile response to lipopolysaccharide is blocked in cyclooxygenase-2(-/-), but not in cyclooxygenase-1(-/-) mice | journal = Brain Res. | volume = 825 | issue = 1–2 | pages = 86–94 |date=April 1999 | pmid = 10216176 | doi = 10.1016/S0006-8993(99)01225-1| s2cid = 38071906 }}
• {{cite journal |vauthors=Luong C, Miller A, Barnett J, Chow J, Ramesha C, Browner MF | title = Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2 | journal = Nat. Struct. Biol. | volume = 3 | issue = 11 | pages = 927–33 |date=November 1996 | pmid = 8901870 | doi = 10.1038/nsb1196-927| s2cid = 24829484 }}
• {{cite journal |vauthors=Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR | title = Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 90 | issue = 24 | pages = 11693–7 |date=December 1993 | pmid = 8265610 | pmc = 48050 | doi = 10.1073/pnas.90.24.11693| bibcode = 1993PNAS...9011693M | doi-access = free }}
• {{cite journal |vauthors=Mitchell JA, Warner TD | title = Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy | journal = Br. J. Pharmacol. | volume = 128 | issue = 6 | pages = 1121–32 |date=November 1999 | pmid = 10578123 | pmc = 1571744 | doi = 10.1038/sj.bjp.0702897 }}
• {{cite journal |vauthors=O'Banion MK, Winn VD, Young DA | title = cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 89 | issue = 11 | pages = 4888–92 |date=June 1992 | pmid = 1594589 | pmc = 49193 | doi = 10.1073/pnas.89.11.4888| bibcode = 1992PNAS...89.4888O | doi-access = free }}
• {{cite journal | author = Patrono C | title = Aspirin: new cardiovascular uses for an old drug | journal = Am. J. Med. | volume = 110 | issue = 1A | pages = 62S–65S |date=January 2001 | pmid = 11166001 | doi = 10.1016/S0002-9343(00)00645-8}}
• {{cite journal | author = Prescott LF | title = Paracetamol: past, present, and future | journal = Am J Ther | volume = 7 | issue = 2 | pages = 143–7 |date=March 2000 | doi = 10.1097/00045391-200007020-00011 | pmid = 11319582 | s2cid = 7754908 }}
• {{cite journal |vauthors=Riendeau D, Percival MD, Boyce S, Brideau C, Charleson S, Cromlish W, Ethier D, Evans J, Falgueyret JP, Ford-Hutchinson AW, Gordon R, Greig G, Gresser M, Guay J, Kargman S, Léger S, Mancini JA, O'Neill G, Ouellet M, Rodger IW, Thérien M, Wang Z, Webb JK, Wong E, Chan CC | title = Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor | journal = Br. J. Pharmacol. | volume = 121 | issue = 1 | pages = 105–17 |date=May 1997 | pmid = 9146894 | pmc = 1564640 | doi = 10.1038/sj.bjp.0701076 }}
• {{cite journal |vauthors=Riendeau D, Percival MD, Brideau C, Charleson S, Dubé D, Ethier D, Falgueyret JP, Friesen RW, Gordon R, Greig G, Guay J, Mancini J, Ouellet M, Wong E, Xu L, Boyce S, Visco D, Girard Y, Prasit P, Zamboni R, Rodger IW, Gresser M, Ford-Hutchinson AW, Young RN, Chan CC | title = Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2 | journal = J. Pharmacol. Exp. Ther. | volume = 296 | issue = 2 | pages = 558–66 |date=February 2001 | pmid = 11160644 }}
• {{cite journal |vauthors=Samad TA, Moore KA, Sapirstein A, Billet S, Allchorne A, Poole S, Bonventre JV, Woolf CJ | title = Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity | journal = Nature | volume = 410 | issue = 6827 | pages = 471–5 |date=March 2001 | pmid = 11260714 | doi = 10.1038/35068566 | bibcode = 2001Natur.410..471S | s2cid = 4428033 }}
• {{cite journal | author = Samuelsson B | title = From studies of biochemical mechanism to novel biological mediators: prostaglandin endoperoxides, thromboxanes, and leukotrienes. Nobel Lecture, 8 December 1982 | journal = Biosci. Rep. | volume = 3 | issue = 9 | pages = 791–813 |date=September 1983 | pmid = 6315101 | doi = 10.1007/BF01133779| s2cid = 86802611 }}
• {{cite journal |vauthors=Simmons DL, Botting RM, Robertson PM, Madsen ML, Vane JR | title = Induction of an acetaminophen-sensitive cyclooxygenase with reduced sensitivity to nonsteroid antiinflammatory drugs | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 96 | issue = 6 | pages = 3275–80 |date=March 1999 | pmid = 10077674 | pmc = 15932 | doi = 10.1073/pnas.96.6.3275| bibcode = 1999PNAS...96.3275S | doi-access = free }}
• {{cite journal |vauthors=Svensson CI, Yaksh TL | title = The spinal phospholipase-cyclooxygenase-prostanoid cascade in nociceptive processing | journal = Annu. Rev. Pharmacol. Toxicol. | volume = 42 | pages = 553–83 | year = 2002 | pmid = 11807183 | doi = 10.1146/annurev.pharmtox.42.092401.143905 }}
• {{cite journal |vauthors=Tanaka A, Araki H, Hase S, Komoike Y, Takeuchi K | title = Up-regulation of COX-2 by inhibition of COX-1 in the rat: a key to NSAID-induced gastric injury | journal = Aliment. Pharmacol. Ther. | volume = 16 Suppl 2 | pages = 90–101 |date=April 2002 | pmid = 11966529 | doi = 10.1046/j.1365-2036.16.s2.22.x| doi-access = free }}
• {{cite journal |vauthors=Turini ME, DuBois RN | title = Cyclooxygenase-2: a therapeutic target | journal = Annu. Rev. Med. | volume = 53 | pages = 35–57 | year = 2002 | pmid = 11818462 | doi = 10.1146/annurev.med.53.082901.103952 }}
• {{cite journal | author = Vane JR | title = The fight against rheumatism: from willow bark to COX-1 sparing drugs | journal = J. Physiol. Pharmacol. | volume = 51 | issue = 4 Pt 1 | pages = 573–86 |date=December 2000 | pmid = 11192932 }}
• {{cite journal | author = Vane JR | title = Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs | journal = Nature New Biology | volume = 231 | issue = 25 | pages = 232–5 |date=June 1971 | pmid = 5284360 | doi = 10.1038/newbio231232a0}}
• {{cite journal |vauthors=Warner TD, Giuliano F, Vojnovic I, Bukasa A, Mitchell JA, Vane JR | title = Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 96 | issue = 13 | pages = 7563–8 |date=June 1999 | pmid = 10377455 | pmc = 22126 | doi = 10.1073/pnas.96.13.7563| bibcode = 1999PNAS...96.7563W | doi-access = free }}
• {{cite journal |vauthors=Wolfe MM, Lichtenstein DR, Singh G | title = Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs | journal = N. Engl. J. Med. | volume = 340 | issue = 24 | pages = 1888–99 |date=June 1999 | pmid = 10369853 | doi = 10.1056/NEJM199906173402407 }}
• {{cite journal |vauthors=Xie WL, Chipman JG, Robertson DL, Erikson RL, Simmons DL | title = Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 88 | issue = 7 | pages = 2692–6 |date=April 1991 | pmid = 1849272 | pmc = 51304 | doi = 10.1073/pnas.88.7.2692| bibcode = 1991PNAS...88.2692X | doi-access = free }}

{{refend}}

{{Oxygenases}}

{{Prostanoidergics}}

{{Enzymes}}

{{Portal bar|Biology|border=no}}

Category:EC 1.14.99

Category:Integral membrane proteins